Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
- 19 November 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cardiology
- Vol. 18 (3), 194-209
- https://doi.org/10.1038/s41569-020-00469-1
Abstract
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive inflammation and respiratory disease, with cytokine storm and acute respiratory distress syndrome implicated in the most severe cases. Thrombotic complications are a major cause of morbidity and mortality in patients with COVID-19. Patients with pre-existing cardiovascular disease and/or traditional cardiovascular risk factors, including obesity, diabetes mellitus, hypertension and advanced age, are at the highest risk of death from COVID-19. In this Review, we summarize new lines of evidence that point to both platelet and endothelial dysfunction as essential components of COVID-19 pathology and describe the mechanisms that might account for the contribution of cardiovascular risk factors to the most severe outcomes in COVID-19. We highlight the distinct contributions of coagulopathy, thrombocytopathy and endotheliopathy to the pathogenesis of COVID-19 and discuss potential therapeutic strategies in the management of patients with COVD-19. Harnessing the expertise of the biomedical and clinical communities is imperative to expand the available therapeutics beyond anticoagulants and to target both thrombocytopathy and endotheliopathy. Only with such collaborative efforts can we better prepare for further waves and for future coronavirus-related pandemics.This publication has 250 references indexed in Scilit:
- Platelet Granule Exocytosis: A Comparison with Chromaffin CellsFrontiers in Endocrinology, 2013
- In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1)Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic StudyPLOS ONE, 2012
- Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxaneJCI Insight, 2011
- SIRT‐1 and vascular endothelial dysfunction with ageing in mice and humansJournal Of Physiology-London, 2011
- Prostacyclin: An Inflammatory ParadoxFrontiers in Pharmacology, 2011
- Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexesNature Medicine, 2010
- Acceleration of Cardiovascular Disease by a Dysfunctional Prostacyclin Receptor MutationCirculation Research, 2008
- Does Increased Oxidative Stress Cause Hypertension?Diabetes Care, 2008
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980